Skip to main content
. Author manuscript; available in PMC: 2012 Sep 14.
Published in final edited form as: Mol Imaging. 2012 Sep-Oct;11(5):426–432.

Figure 1.

Figure 1

Figure 1

Biodistribution of 18F-FMAU at 3h after tail vein administration in athymic castrated (red bars) and noncastrated (blue bars) male mice bearing either (a) CWR22 or (b) PC3 implanted human prostate cancer xenografts. In both animals, the organs with the highest tracer uptake were the liver, spleen, and kidneys. Note the generalized organ tracer retention in the castrated mice. The CWR22 tumor-to-liver and tumor-to-blood uptake ratios were significantly higher in the noncastrated animal.